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Abstract
Diffuse alveolar hemorrhage (DAH) syndrome has a mortality
rate of 30 to 60%. A 15-year-old male patient presented with a
seven-day abdominal pain, vomiting, non-dysenteric diarrhea,
conjunctival injection, and fever. Chest radiography revealed
bilateral interstitial infiltrates predominating in the lower left
lobe. The patient’s condition worsened within hours, with the
development of massive hemoptysis, acute respiratory distress syndrome (ARDS), arterial hypotension, and hematocrit
decline requiring mechanical ventilation. A chest computed
tomography (CT) showed ground-glass opacities with consolidation areas in lower lobes, diffuse tree-in-bud opacities, and
centrilobular nodules. A bronchoscopy was conducted with-

out endoluminal lesions and bronchoalveolar lavage (BAL)
consistent with alveolar hemorrhage. DAH was diagnosed,
and the patient received therapy with intravenous methylprednisolone. The outcome of treatment was successful after
eight days of mechanical ventilation. Leptospirosis was diagnosed by serology after discharge. The laboratory findings
were normal, and a chest CT scan showed the resolution of
the infiltrates. Early recognition of severe hemorrhagic pulmonary syndrome, which has a high mortality rate, is crucial.
Therefore, leptospirosis should be suspected as a differential
diagnosis in every patient with alveolar hemorrhage, ARDS
manifestations, and epidemiological factors.

Introduction

bladder, while chest radiography revealed bilateral interstitial infiltrates predominantly in the lower left lobe
(Figure 1). Severe abdominal sepsis was diagnosed,
and treatment with ceftriaxone and metronidazole was
initiated.

Diffuse alveolar hemorrhage syndrome (DAH) is characterized by hemoptysis, falling hemoglobin, and diffuse lung infiltrates on chest radiography.[1] There are
numerous causes of DAH, including the severe pulmonary form of leptospirosis. The mortality rate of this
clinical presentation is 30 to 60%.[2]

Case Presentation
A 15-year-old male patient presented with a sevenday abdominal pain, vomiting, non-dysenteric diarrhea, conjunctival injection, and fever. He had been
exposed to a course of water resulting from a flood
days before. Physical examination revealed arterial hypotension, which initially responded to volume expansion with crystalloids; epigastric pain; and adequate
breathing.
Laboratory tests revealed leukocytosis, anemia,
metabolic acidosis, hypochloremia, hyperlactatemia,
renal failure, coagulopathy, hypertransaminasemia,
and high C-reactive protein. In addition, abdominal
ultrasound showed much biliary sludge in the gall-
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The patient’s condition worsened within hours, with
the development of massive hemoptysis, arterial hypotension, and hematocrit decline requiring mechanical ventilation, to severe sepsis from a possible abdominal or pulmonary source. Vancomycin and clarithromycin were added to treatment. The patient’s condition progressed to severe (ARDS), requiring salvage
therapies such as prone positioning and recruitment
maneuvers.
A chest computed tomography (CT) showed groundglass opacities with consolidation areas in lower lobes,
diffuse tree-in-bud opacities, and centrilobular nodules
(Figure 2). In addition, a bronchoscopy was conducted
without endoluminal lesions and sequential lavages
consistent with alveolar hemorrhage.
DAH was diagnosed, and the patient received therapy
with intravenous pulse methylprednisolone. The laboratory results revealed normal renal function and neg-
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Figure 1. Chest X-ray on admission: bilateral alveolar opacities predominate in the lower left lung field.

ative autoantibody profiles (ANA, antiDNA, ENA, and
ANCA).

urine of infected animals; it enters through eroded skin
or mucous membranes.[3]

Blood and urine cultures, pneumococcal urinary antigen, bronchoalveolar lavage (BAL)—bacteria cultures,
respiratory virus polymerase chain reaction (PCR),
Chlamydia pneumoniae, Chlamydia psittaci, Mycoplasma
pneumoniae, mycobacteria, and fungi—and serological
tests for leptospirosis (microscopic agglutination test
[MAT]), hantavirus, human immunodeficiency virus
(HIV), and hepatitis B and C were all negative.

Concerning its pathogenesis, in the bacteremic phase,
it spreads to tissues and organs. In the immune phase,
between five and seven days after infection, antibodies appear in the blood, and leptospira are expelled in
urine. After infection, a systemic vasculitis occurs with
damage of endothelial cell membranes of the capillaries
that can cause pulmonary hemorrhage, tubular and interstitial nephritis, intrahepatic cholestasis, meningeal
inflammation, and bleeding secondary to vasculitis and
thrombocytopenia.

The patient received treatment with ceftriaxone. The
outcome was successful after eight days of mechanical ventilation. After discharge, a second MAT for leptospirosis was positive (1:200). The laboratory findings
were normal, and a chest CT scan showed the resolution of the infiltrates (Figure 3).

Discussion
Leptospirosis is a worldwide zoonosis present in urban and rural areas. Floods and hurricanes are the
main risks factor for leptospirosis infection. In human
beings, the infection occurs by direct contact with the
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The clinical course of leptospirosis is variable, from
nonspecific fever episodes to severe forms of renal failure or pulmonary hemorrhage with a mortality of up
to 50%.
Three forms of clinical presentation are described:
Anicteric leptospirosis (90% of cases): manifests itself
with fever, myalgias, headaches, and aseptic meningitis; conjunctival injection is characteristic. After five to
seven days, if the disease is not self-limited, the systemic infection appears.
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Figure 2. Chest computed tomography on admission: ground glass infiltrates with consolidation areas predominantly in lower lobes, associated
with diffuse tree-in-bud infiltrate and centrilobular nodules.

Figure 3. Control chest computed tomography: normal.

Icteric leptospirosis or Weil syndrome (5–10%): severe icteric disease; renal failure; hemorrhagic phenomena; and hemodynamic, pulmonary, and neurologic
disorders. It presents with abdominal tenderness and
hepatomegaly in 70% of cases. In addition, petechiae,
ecchymosis, hematemesis, hemoptysis, melena, or enterorrhagia frequently occur.
Severe hemorrhagic pulmonary syndrome: presents
with dyspnea and hemoptysis. Alveolar hemorrhage
presents as ARDS, generally anicteric, without severe
nephropathy, and with mild thrombocytopenia.
Most cases of leptospirosis are diagnosed by serology;
the gold standard test is the MAT. Both serum samples
of our patient were tested for leptospirosis antibodies
using MAT. Although the specificity is high (higher
than 95% in some series), the sensitivity changes acULJRI | https://ir.library.louisville.edu/jri/vol6/iss1/11

cording to the time of illness. MAT was reported to
have a sensitivity of 41% during the first week, 82%
during the second to fourth week, and 96% beyond the
fourth week.[4] Niloofa et al. reported that acute MAT
had a sensitivity of 55.3%, specificity of 95.7%, a positive predictive value (PPV) of 0.95, and a negative predictive value (NPV) of 0.55.[5] It is worth mentioning
that, in Argentina, the definition of a confirmed case
is based on a MAT titer of ≥200 or the presence of seroconversion (two-fold increase in antibody titer or a
positive second MAT test if the first one is negative).[6]
The most frequent tomographic findings are groundglass opacities, nodules, consolidation, crazy-paving
pattern, and pleural effusion. The tomographic findings present a diffuse and symmetric distribution, with
a predominance of the lower lobes in most cases.[7]
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Bronchoscopy in severe pulmonary leptospirosis enables early detection of the alveolar hemorrhage.[8] In
addition, early antibiotic treatment shortens fever and
length of hospitalization. However, the benefits of antibiotics after the fifth day of illness are debatable.[6]
The role of corticosteroids in leptospirosis with lung involvement is controversial. Four studies with methodological limitations demonstrated its benefit in severe
lung disease when administered early. A randomized
controlled trial showed that corticosteroids are ineffective and may increase the risk of infection.[9] A doubleblind, randomized clinical trial is underway to evaluate
treatment efficacy with methylprednisolone pulse therapy compared with placebo in patients with lung involvement due to leptospira.[10]
Another treatment used in severe forms is cyclophosphamide; in Trivedi et al.’s study of 33 patients treated
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with cyclophosphamide, 22 (66.7%) survived, while in
the control group of 32 patients, 3 (9.4%) survived.[11]
A systematic review in Sri Lanka evaluated the benefits of extracorporeal membrane oxygenation (ECMO)
and plasmapheresis in severe pulmonary leptospirosis; one clinical trial showed significant survival with
plasmapheresis, but the study’s design has significant limitations. Another study described more prolonged survival with ECMO. Current evidence is insufficient to recommend routine use of plasmapheresis or
ECMO.[12]
Conclusions
Early recognition of severe hemorrhagic pulmonary
syndrome, which has a high mortality rate, is crucial. Leptospirosis should be suspected as a differential
diagnosis in every patient with alveolar hemorrhage,
ARDS manifestations, and epidemiological factors.
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